Thelansis

Psoriatic Arthritis (PsA) Market Outlook Thelansis’s “Psoriatic Arthritis (PsA) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Psoriatic Arthritis (PsA) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Key business questions answered: How can drug development and lifecycle management strategies be optimized across G8 markets (US, EU5, Japan, and China)? How large is the patient population in terms of incidence, prevalence, segments, and those receiving drug treatments? What is the 10-year market outlook for sales and patient share? Which events will have the greatest impact on the market’s ...

Psoriatic Arthritis (PsA) Market Outlook Thelansis’s “Psoriatic Arthritis (PsA) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Psoriatic Arthritis (PsA) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Psoriatic Arthritis (PsA) Overview Psoriatic arthritis (PsA) is a chronic autoimmune inflammatory condition primarily affecting the joints and the areas where tendons and ligaments connect to bones. It typically co-occurs with a skin condition known as psoriasis. Enthesitis is among its most common distinguishing features. Other clinical manifestations include joint swelling, painful and itchy red patches, and the accumulation o...

  Psoriatic arthritis (PsA) is a chronic inflammatory autoimmune disease associated with joints and the place where tendons and ligaments are connected to bone and usually occurs in combination with a skin disorder called psoriasis. Enthesitis is one of the most common characteristic features. Other clinical features, including swelling joints, itchy-painful red patches, silvery while building up dead skin cells, and PsA also affect the sacroiliac joint of the pelvic and spine, causing stiffness in and around the neck and back. The exact cause of psoriatic arthritis is still unknown. It starts emerging in individuals aged 30 to 50 and can begin as early as childhood. Both genders are equally at the same risk level. The genetic epidemiology of PsA also supports its unique status. PsA has been associated with human leukocyte antigen (HLA) class 1 alleles as opposed to the type 2 alleles associated with RA. Extra-articular manifestations of PsA are also different from those of RA. In ...